Novel Predictors of New Pacemaker Implantation and Associated Outcomes Among Patients Undergoing TAVR for Aortic Regurgitation in the ALIGN-AR Trial
We Recommend
Disclosures
Within the prior 24 months, I have had a financial relationship with a company producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients:
- Consultant Fee/Honoraria/Speaker's Bureau - Edwards Lifesciences; Medtronic; Boston Scientific Corporation; Abbott
- Equity/Stock(s)/Options - Excision Medical; Transmural Sesame LLC
- Structural Heart Advisory Board - Shockwave Medical